8-K//Current report
Maze Therapeutics, Inc. 8-K
Accession 0001193125-25-269624
$MAZECIK 0001842295operating
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:21 PM ET
Size
381.5 KB
Accession
0001193125-25-269624
Documents
- 8-Kmaze-20251106.htmPrimary
8-K
- EX-99.1maze-ex99_1.htm
EX-99.1
- GRAPHICimg92905542_0.jpg
GRAPHIC
- EX-101.SCHmaze-20251106.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-269624-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLmaze-20251106_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Maze Therapeutics, Inc.
CIK 0001842295
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001842295
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:21 PM ET
- Size
- 381.5 KB